5 Amino 1MQ

5-Amino-1MQ is a laboratory-developed small molecule investigated for its ability to inhibit nicotinamide N-methyltransferase (NNMT). Its proposed relevance to body-fat regulation and metabolic processes remains a research question rather than an established clinical benefit.

NNMT participates in nicotinamide metabolism and is expressed in tissues including the liver and body fat. The guide links elevated NNMT activity with greater lipid accumulation and altered metabolic function, but these associations alone do not establish causation.

The principal mechanism under investigation is suppression of NNMT enzyme activity. Researchers have explored whether this could alter metabolic pathways involved in lipid handling and cellular energy balance. The guide also mentions mitochondrial processes, without providing enough detail to establish a specific mitochondrial mechanism.

1. 01

   Molecular target

2. 02

   Cellular signal

3. 03

   Biological process

LEVEL 02 · Preclinical research

Laboratory or animal research exists. Findings do not transfer reliably to people.

Evidence levels reflect the state of documented research only. They are not rankings of popularity, quality or suitability, and a higher level never implies that a compound is an approved medicine.

The source guide presents this compound as a candidate for research into reduced body fat and changes in metabolic function. It also suggests possible effects on perceived energy, without supplying evidence sufficient to substantiate that claim. The guide characterizes tolerability favorably and mentions digestive symptoms, but does not identify supporting safety studies.

Source: The Complete Guide to Peptides: Unlocking the Secrets to Health, Healing and Longevity — Hack Smith, Chapter 6, Introduction to Peptides (page references not verified)

Summarised in our own wording from the cited reference. The reference is a popular guide, not peer-reviewed literature; its statements are reported here as source claims rather than established facts.

Dosage, reconstitution and administration guidance is deliberately excluded from this platform.

The supplied material does not establish whether the proposed metabolic effects translate into meaningful benefits in humans. The strength of the mitochondrial claims and the consequences of sustained NNMT inhibition remain unclear.

Safety data are limited, particularly for prolonged exposure and human outcomes. The guide's favorable tolerability description and mention of digestive symptoms should not be treated as a validated safety profile. This information is educational and is not medical advice.

Research-stage compound unless otherwise established by a competent authority. Regulatory classification differs between jurisdictions and can change over time; nothing here indicates marketing authorisation.

Primary reference for this entry:

The Complete Guide to Peptides: Unlocking the Secrets to Health, Healing and Longevity — Hack Smith, Chapter 6, Introduction to Peptides (page references not verified)

Suggested literature search terms taken from the source. They are search starting points, not citations to specific studies.

• “5-Amino-lMQ fat loss studies”
• “NNMT inhibition and fat metabolism”
• “5-Amino-lMQ clinical trials”

Editorial status

source reviewed

Last updated

2026-09-14

Last reviewed

2026-09-13

Language

EN